|
Name |
(1R,6R,10R)-5-(5,6-dimethylhept-3-en-2-yl)-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadeca-8,18-dien-13-ol
|
Molecular Formula | C28H42O3 | |
IUPAC Name* |
(1R,6R,10R)-5-(5,6-dimethylhept-3-en-2-yl)-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadeca-8,18-dien-13-ol
|
|
SMILES |
CC(C)C(C)C=CC(C)C1CCC2[C@@]1(CC=C3[C@@]24C=CC5([C@@]3(CCC(C5)O)C)OO4)C
|
|
InChI |
InChI=1S/C28H42O3/c1-18(2)19(3)7-8-20(4)22-9-10-23-25(22,5)13-12-24-26(6)14-11-21(29)17-27(26)15-16-28(23,24)31-30-27/h7-8,12,15-16,18-23,29H,9-11,13-14,17H2,1-6H3/t19?,20?,21?,22?,23?,25-,26-,27?,28-/m1/s1
|
|
InChIKey |
FWPYIYVSYQRISA-ADUMQTOCSA-N
|
|
Synonyms |
5,8-Epidioxyergosta-6,9(11),22-trien-3-ol; 86363-50-0
|
|
CAS | NA | |
PubChem CID | 146159992 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 426.6 | ALogp: | 6.1 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 38.7 | Aromatic Rings: | 6 |
Heavy Atoms: | 31 | QED Weighted: | 0.419 |
Caco-2 Permeability: | -4.616 | MDCK Permeability: | 0.00004570 |
Pgp-inhibitor: | 0.263 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.038 |
Blood-Brain-Barrier Penetration (BBB): | 0.812 | Plasma Protein Binding (PPB): | 98.45% |
Volume Distribution (VD): | 1.53 | Fu: | 1.47% |
CYP1A2-inhibitor: | 0.029 | CYP1A2-substrate: | 0.924 |
CYP2C19-inhibitor: | 0.131 | CYP2C19-substrate: | 0.956 |
CYP2C9-inhibitor: | 0.493 | CYP2C9-substrate: | 0.068 |
CYP2D6-inhibitor: | 0.031 | CYP2D6-substrate: | 0.316 |
CYP3A4-inhibitor: | 0.947 | CYP3A4-substrate: | 0.929 |
Clearance (CL): | 7.197 | Half-life (T1/2): | 0.113 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.031 |
Drug-inuced Liver Injury (DILI): | 0.021 | AMES Toxicity: | 0.028 |
Rat Oral Acute Toxicity: | 0.116 | Maximum Recommended Daily Dose: | 0.307 |
Skin Sensitization: | 0.044 | Carcinogencity: | 0.141 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.029 |
Respiratory Toxicity: | 0.586 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005014 | 1.000 | D0G8OC | 0.407 | ||||
ENC004857 | 1.000 | D06JPB | 0.395 | ||||
ENC005242 | 0.870 | D0G5CF | 0.377 | ||||
ENC005015 | 0.654 | D0Y7LD | 0.310 | ||||
ENC005779 | 0.654 | D0N1TP | 0.292 | ||||
ENC004740 | 0.654 | D01QUS | 0.261 | ||||
ENC001640 | 0.654 | D08SVH | 0.254 | ||||
ENC005013 | 0.654 | D0K5WS | 0.252 | ||||
ENC002327 | 0.545 | D0B4RU | 0.230 | ||||
ENC004858 | 0.513 | D02ZGI | 0.226 |